Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Analgesic or Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism) or Stimulant

Use the filters below to narrow your results.

generic:
Codeine (2)
brand:
None (47) · (multiple, generic dominant) (1) · Benzedrex (1) · Darvon (1) · Demerol (1) · Dilaudid (1) · Dolophine (1) · Duragesic (1) · Nubain (1) · Nucynta (1) · Nuplazid (1) · Opana (1) · Stadol (1) · Suboxone (1) · Talwin (1) · Vicodin (1)
classes: (Click arrow to add another value)
mechanism:
Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · Mu-opioid receptor agonist (4) · Potent mu-opioid receptor agonist (3) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2)
uses:
None (60) · Hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Investigational for psychosis in other dementias and as augmentation for depression. (1) · Mild to moderate pain; cough suppression (low-dose). (1)
starting dose:
None (60) · 34 mg PO once daily (1) · Adult: 15–60 mg every 4 hours as needed. (1)
preparations:
None (60) · 10 mg, 34 mg capsules/tablets (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)
fda max:
None (60) · 34 mg/d (1) · 360 mg/day (1)
routes:
None (60) · Oral (1) · PO (only formulation marketed in the US). (1)
onset:
None (60) · 30–60 min (PO) (1) · Benefit over weeks of dosing (1)
duration:
None (60) · 4–6 hours (1) · Daily dosing (1)
halflife:
None (60) · 2.5–3 hours (1) · ~57 hours (parent), ~200 h (active metabolite) (1)
bioavailability:
None (60) · Not characterized; oral dosing once daily (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)
pregnancy:
None (60) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Limited data; avoid (1)
legal:
None (60) · Rx. FDA black-box warning for increased mortality in elderly patients with dementia-related psychosis (class warning shared with all antipsychotics) (1) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)

Showing below up to 62 results in range #1 to #62.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"